Cancer Family
Neoplasm
CI-CAN-00000001Explore in graph →
Non-malignant22,961 active trials259 approved drugs4,031 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000001Explore in graph →
Clinical trials
105,853 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01680796 | Dovitinib Combined With Bortezomib and Dexamethasone for Relapsed/Refractory Multiple Myeloma | withdrawn | Phase 1 | 0 | University of FloridaOTHER | 0 | Feb 20, 2013 | clinicaltrials |
| NCT01101412 | Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Feb 15, 2013 | clinicaltrials |
| NCT00137358 | Radiation With Chemotherapy and a Study Drug to the Para-Aortic Nodes in Cervical Cancer | withdrawn | Phase 1 | 0 | University of Alabama at BirminghamOTHER | 1 | Jan 24, 2013 | clinicaltrials |
| NCT01506427 | A Study of [F-18]HX4 (PET Imaging)Evaluated in Head and Neck Cancer Patients | withdrawn | Phase 1 / Phase 2 | 0 | Siemens Molecular ImagingINDUSTRY | 1 | Dec 17, 2012 | clinicaltrials |
| NCT00734864 | Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma | withdrawn | Phase 1 | 0 | Annick DesjardinsOTHER | 1 | Nov 21, 2012 | clinicaltrials |
| NCT01568632 | Imetelstat for Children With Refractory or Recurrent Solid Tumors and Lymphoma | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 0 | Nov 21, 2012 | clinicaltrials |
| NCT00002761 | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia | withdrawn | Phase 1 / Phase 2 | 0 | Columbia UniversityOTHER | 0 | Nov 19, 2012 | clinicaltrials |
| NCT01608139 | Study of Curcumin, Vorinostat, and Sorafenib | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Oct 19, 2012 | clinicaltrials |
| NCT00972101 | Infusion of Expanded Cord Blood T Cells | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Oct 11, 2012 | clinicaltrials |
| NCT00093548 | Vaccine Therapy in Treating Patients With Stage II, Stage IIIA, Stage IIIB, or Stage IVA Liver Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Jonsson Comprehensive Cancer CenterOTHER | 0 | Oct 4, 2012 | clinicaltrials |
| NCT00098462 | Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Jonsson Comprehensive Cancer CenterOTHER | 0 | Oct 4, 2012 | clinicaltrials |
| NCT00738335 | Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain Metastases | withdrawn | Phase 1 | 0 | University of California, San FranciscoOTHER | 1 | Oct 4, 2012 | clinicaltrials |
| NCT00027521 | Electroporation Therapy With Bleomycin in Treating Patients With Pancreatic Cancer | withdrawn | Phase 1 | 0 | Ichor Medical Systems IncorporatedINDUSTRY | 0 | Sep 19, 2012 | clinicaltrials |
| NCT00293436 | Celecoxib and Erlotinib in Treating Patients With Liver Cancer | withdrawn | Phase 1 / Phase 2 | 0 | University of California, San FranciscoOTHER | 1 | Sep 17, 2012 | clinicaltrials |
| NCT00025532 | Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer | withdrawn | Phase 1 | 0 | University of California, San FranciscoOTHER | 1 | Sep 14, 2012 | clinicaltrials |
| NCT00520325 | A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropenia | withdrawn | Phase 1 | 0 | Enzon Pharmaceuticals, Inc.INDUSTRY | 0 | Sep 5, 2012 | clinicaltrials |
| NCT01521299 | A Dose Escalation Study of Hydroxyurea in Combination With SCH900776 in Advanced Malignant Solid Tumors | withdrawn | Phase 1 | 0 | Dartmouth-Hitchcock Medical CenterOTHER | 0 | Aug 28, 2012 | clinicaltrials |
| NCT01416961 | Integration of Neutron Therapy in the Treatment Plan for Stage III Non-Small Cell Lung Cancer (NSCLC) | withdrawn | Phase 1 | 0 | Barbara Ann Karmanos Cancer InstituteOTHER | 0 | Aug 22, 2012 | clinicaltrials |
| NCT00962715 | Reactogenicity, Immunogenicity of Trivalent Influenza Vaccine With Recombinant Interferon Alpha Among Chronic Lymphocytic Leukemia | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Aug 3, 2012 | clinicaltrials |
| NCT01168882 | Safety and Tolerability of RGB-286638 in Patients With Selected, Relapsed or Refractory Hematological Malignancies | withdrawn | Phase 1 | 0 | AgennixINDUSTRY | 0 | Aug 2, 2012 | clinicaltrials |
| NCT00800566 | Oral Clofarabine in Chronic Lymphocytic Leukemia (CLL) | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 1, 2012 | clinicaltrials |
| NCT00939172 | TTP607 in Refractory Solid Malignancies | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jul 31, 2012 | clinicaltrials |
| NCT01139359 | Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma | withdrawn | Phase 1 | 0 | Alaunos TherapeuticsINDUSTRY | 0 | Jul 19, 2012 | clinicaltrials |
| NCT01296659 | Study of Oral Ridaforolimus in Combination With Standard Chemotherapy for Soft Tissue Sarcoma | withdrawn | Phase 1 | 0 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jul 12, 2012 | clinicaltrials |
| NCT00003979 | CHS 828 in Treating Patients With Solid Tumors | withdrawn | Phase 1 | 0 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT00003985 | KRN7000 in Treating Patients With Solid Tumors | withdrawn | Phase 1 | 0 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT01333423 | Maximum Tolerated Dose (MTD) of Liposomal Doxorubicin in Combination With Seliciclib for Patients With Metastatic Triple Negative Breast Cancer (TNBC) | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jun 26, 2012 | clinicaltrials |
| NCT00886496 | Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia | withdrawn | Phase 1 | 0 | Enzon Pharmaceuticals, Inc.INDUSTRY | 1 | Jun 20, 2012 | clinicaltrials |
| NCT01491139 | Phase I Study of Olaparib With Cisplatin Based Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck(ORCA) | withdrawn | Phase 1 | 0 | University College, LondonOTHER | 0 | May 30, 2012 | clinicaltrials |
| NCT00442741 | Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension) | withdrawn | Phase 1 | 0 | Novartis PharmaceuticalsINDUSTRY | 0 | Apr 25, 2012 | clinicaltrials |
| NCT00005827 | Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer | withdrawn | Phase 1 | 0 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Apr 24, 2012 | clinicaltrials |
| NCT00515957 | Study of LMP1- and LMP2- Specific Cytotoxic T-Lymphocytes (CTL)(DELLA) | withdrawn | Phase 1 | 0 | Baylor College of MedicineOTHER | 0 | Apr 16, 2012 | clinicaltrials |
| NCT00503932 | Proton Therapy With Capecitabine for Rectal Cancer | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Mar 22, 2012 | clinicaltrials |
| NCT01353482 | A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma(MESO-02) | withdrawn | Phase 1 / Phase 2 | 0 | University College, LondonOTHER | 0 | Mar 22, 2012 | clinicaltrials |
| NCT00445757 | Stereotactic Radiation Therapy in Treating Patients With Kidney Tumors | withdrawn | Phase 1 | 0 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 20, 2012 | clinicaltrials |
| NCT00429078 | Trial of 2nd Generation Anti-CEA Designer T Cells in Gastric Cancer | withdrawn | Phase 1 | 0 | Roger Williams Medical CenterOTHER | 0 | Mar 2, 2012 | clinicaltrials |
| NCT01452334 | Safety Study of Anti-Programmed Death-Ligand 1 in Hematologic Malignancy | withdrawn | Phase 1 | 0 | Bristol-Myers SquibbINDUSTRY | 0 | Feb 23, 2012 | clinicaltrials |
| NCT01189513 | SCH-900105 in Recurrent Glioblastoma | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Feb 20, 2012 | clinicaltrials |
| NCT00411593 | Phase I-II for Patients With Recurrent or Refractory Non-small Cell Lung Cancer (NSCLC) | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Feb 8, 2012 | clinicaltrials |
| NCT01146171 | Japanese Phase 1 Study of BMS-844203 (CT322) | withdrawn | Phase 1 | 0 | Bristol-Myers SquibbINDUSTRY | 1 | Feb 7, 2012 | clinicaltrials |
| NCT01409187 | IPI-Biotherapy for Patients Previously Treated With Cytotoxic Drugs With Metastatic Melanoma | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jan 26, 2012 | clinicaltrials |
| NCT01456182 | Phase 1B- Open Label Dose-Ranging Study of Oral AFX-2 in Adults With Chronic Lymphocytic Leukemia | withdrawn | Phase 1 | 0 | Afexa Life Sciences IncINDUSTRY | 1 | Jan 25, 2012 | clinicaltrials |
| NCT00780988 | Feasibility of Autologous Tumor Cell-TLR9 Agonist Vaccination for Metastatic Colorectal Cancer | withdrawn | Phase 1 | 0 | Stanford UniversityOTHER | 1 | Jan 24, 2012 | clinicaltrials |
| NCT01441388 | A Study Of Crizotinib Plus VEGF Inhibitor Combinations In Patients With Advanced Solid Tumors. | withdrawn | Phase 1 | 0 | PfizerINDUSTRY | 0 | Dec 20, 2011 | clinicaltrials |
| NCT01153113 | Human Telomerase Reverse Transcriptase Messenger RNA (hTERT mRNA) Transfected Dendritic Cell Vaccines | withdrawn | Phase 1 / Phase 2 | 0 | University of FloridaOTHER | 0 | Dec 2, 2011 | clinicaltrials |
| NCT00937300 | T-cell Based Immunotherapy for Head and Neck Cancer | withdrawn | Phase 1 | 0 | Inge Marie SvaneOTHER | 1 | Nov 23, 2011 | clinicaltrials |
| NCT00803374 | Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma | withdrawn | Phase 1 | 0 | Bristol-Myers SquibbINDUSTRY | 1 | Nov 21, 2011 | clinicaltrials |
| NCT00118300 | Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer | withdrawn | Phase 1 | 0 | Case Comprehensive Cancer CenterOTHER | 1 | Jul 8, 2011 | clinicaltrials |
| NCT01194193 | Preliminary Anti-tumour Activity of mTor Kinase Inhibitor in Advanced Tumours | withdrawn | Phase 1 | 63 | AstraZenecaINDUSTRY | 0 | May 16, 2011 | clinicaltrials |
| NCT00162513 | Allogeneic Tumor Cell Vaccination in Patients With Chronic Myeloid Leukemia | withdrawn | Phase 1 / Phase 2 | — | Hadassah Medical OrganizationOTHER | 1 | Apr 28, 2011 | clinicaltrials |
Data updated 22 days agoSource updated Feb 20, 2013source: clinicaltrials